I
t has long been known that T regulatory (Tr)1 cells are required to maintain immune homeostasis, yet little is known about the factors that govern early lineage commitment, including chromatin accessibility for the transcription of genes related to the Tr1 program. In a recent study, Karwacz and colleagues have described key roles of the transcription factors IRF1 and BATF during Tr1 cell differentiation in response to IL-27 signaling. These factors modulate the chromatin landscape during induction of the Tr1 cell program: BATF prepares the binding of transcription factors involved in Tr1 cell lineage commitment, and IRF1 transactivates Il10 gene expression and Tr1 cellrelated genes while inhibiting Th17 cell differentiation.
Tr1 cells are a subset of CD4 + T regulatory cells that, in contrast to classical CD4 + T regulatory (Treg) cells, exert a suppressive function that is not associated with the expression of the transcription factor forkhead box P3 (FOXP3). 1 Characteristics of Tr1 cells include the co-expression of LAG-3 and CD49b, 2 as well as a signature cytokine profile that includes copious secretion of IL10 and less substantial production of TGF-β, IFN-γ and IL-5. 3, 4 Although a master transcriptional regulator analogous to FOXP3 in Treg cells has not been identified in Tr1 cells, several mechanisms that regulate Tr1 differentiation have been elucidated. These findings support the potential therapeutic use of Tr1 cells in transplant medicine, in which an expansion of Tr1 cells in mouse models has been reported to successfully induce graft tolerance, or in inflammatory bowel disease, in which clinical trials are underway. 5, 6 Because Tr1 cells can be induced from naive CD4 + T cells, multiple protocols have been developed to generate Tr1 cells. To drive the differentiation of murine CD4 + CD62 hi CD44 lo naive cells into Tr1 cells, Karwacz et al. 7 used a combination of T-cell receptor stimulation (with plate-bound anti-CD3 and anti-CD28 antibodies) and IL-27, a cytokine that binds its receptor and subsequently activates the transcription factors c-Maf and aryl hydrocarbon receptor (AhR), which in turn bind to and transactivate the Il10 and Il21 promoters, respectively. 8 IRF1 and BATF have recently been implicated as regulators of chromatin accessibility and their pioneer-like functions contribute to shaping the epigenetic landscape during Th17( ref. 9 ) and CD8 + T-cell differentiation. 10 The roles of these factors in Tr1 development were first substantiated by quantitative polymerase chain reaction (qPCR) showing that their expression is highly upregulated among early induced transcription factors after in vitro polarization of CD4 + T cells to Tr1 cells.
The contribution of IRF1 and BATF to Tr1 differentiation was confirmed by Karwacz and colleagues, on the basis of the inability of Irf1 −/− and Batf −/− cells to differentiate into Tr1 cells, thus indicating that IRF1 and BATF are required for the differentiation of IL-27-induced Tr1 cells in vitro. The authors also found that Irf1 expression was dependent on STAT1, whereas Batf expression depended on STAT3. To extend these findings to in vivo models, it was tested whether Irf1 −/− and Batf −/− mice could generate Tr1 cells. The induction of experimental autoimmune encephalitis (EAE) in Irf1 −/− mice resulted in more severe clinical phenotypes, as is the case for EAE induced in lymphocyte-deficient Rag2 −/− mice receiving Irf1 −/− CD4 + T cells. This observation was further corroborated by molecular studies showing increased percentages of IL-17A/IFN-γ-producing CD4 + T cells in the central nervous system of Irf1 −/− mice. The role of IRF1 was also tested in another EAE model derived by crossing Irf1 −/− and 2D2 transgenic mice (carrying a T-cell receptor specific for MOG ). Approximately 6% of 2D2 mice spontaneously develop EAE at a low incidence; 11 however, all Irf1 −/− 2D2 mice develop EAE. In vitro studies indicated that Irf1 −/− 2D2 CD4 + cells had increased IL-17A and IFN-γ production after antigen restimulation. These data suggested that IRF1 promoted Tr1 differentiation by contributing to preventing Th17 polarization. This idea was also supported by competitive inhibition experiments between IRF1 and IRF4 (which stimulates Th17 differentiation).
Because IRF1 and BATF are necessary for Tr1 development, and they have known roles in regulating chromatin accessibility and pioneer-like function in the differentiation of Th17 cells, the effects of IRF1 and BATF on the chromatin landscape were studied.
After CD4 + cell polarization for 3 days by IL-27 toward a Tr1 phenotype, chromatin immunoprecipitation (ChIP) followed by qPCR indicated that IRF1 bound three/four different sites in the Il10 locus, whereas BATF bound two. These factors have overlapping binding sites, and sequential ChIP assay demonstrated strong co-occupancy at the two sites. The interrelation between IRF1 and BATF was revealed by ChIP studies showing a decrease in BATF binding to Il10 in Irf1 −/− mice and decreased IRF1 binding in Batf −/− mice.
To also test whether these two transcription factors influence the distribution of epigenetic marks within the Il10 locus in Tr1 cells, ChIP-seq probed Irf1 −/− and Batf −/− Tr1 cells for the activating marks H3K9Ac and H3K4me, as well as the repressive H3K27me mark. Knockout mice for either gene exhibited a decrease in the activating marks and an increase in the repressive marks, in agreement with these transcription factors influencing Il10 expression via epigenetic modulation.
To define a pioneering role for IRF1 and BATF in Tr1 cell differentiation, assays were conducted to measure chromatin accessibility through transposase accessible chromatin with sequencing (ATAC-seq). Before these studies, two reporter constructs were made; in the first construct, the reporter was driven by the proximal Il10 promoter and contained one of the IRF1-binding sites, and the second construct contained sequences for the other two sharedbinding sites upstream of the Il10 minimal promoter. Direct transactivation of the Il10 gene was achieved with IRF1 but not BATF. ChIP analyses allowed to discern whether IRF1 and BATF were required for the recruitment of other factors known to bind the Il10 locus. Deficiencies in both the IRF1 and BATF genes resulted in decreased binding of AhR, and IRF1 was required for the recruitment of c-Maf.
ATAC-seq was used to compare neutral cytokine conditions (Th0) to Tr1 polarization at different time points after induction (24 and 72 h) together with gene effects (Irf1, Batf, C-maf and AhR). The chromatin landscape of cells from Batf −/− mice was markedly distinct from that of the other knockout animals. Of the 180 000 identified chromatin access sites, Batf deficiency affected over 20000 loci, whereas Irf1 deficiency influenced accessibility at~1200 loci. RNA sequencing of the Irf1 −/− and Batf −/− transcriptome under Tr1 polarizing versus neutral conditions revealed~110 and~500 genes differentially regulated by IRF1 and BATF, respectively. To characterize relevant networks and detect potential binding motifs of poorly characterized murine transcription factors, data gathered from ATAC-seq and RNA sequencing were used to generate an extensive reference bank that combined human and mouse motifs from the ENCODE and CisBP collections as well as extrapolated data from human orthologs and mouse transcription factor family subclasses. Genes found to be differentially expressed in the presence versus absence of Irf1 and Batf, identified by RNA sequencing, and the sequences of peak chromatin access sites for these genes, determined by ATAC-seq, were crossreferenced with sequences in the transcription factor motif database. The resulting interactions, which are summarized in Figure 1 , were visualized with a newly designed interactive interface.
In summary, this study provides new evidence of a key role of BATF and IRF1 in Tr1 differentiation. BATF appears to have broad effects on chromatin reshaping, thus enabling the binding of multiple transcription factors including those involved in Tr1 differentiation, whereas IRF1 is specific to the Tr1 program. Although these data are both novel and important, further studies are required to clarify the concomitant and sequential events associated with Tr1 induction. IRF1 and BATF were selected because of their defined role in Tr1 cell differentiation. However, the expression of multiple additional transcription factors in response to Tr1 cell polarization was not studied further, even when the expression exceeded that of IRF1 and BATF. In addition, the relationship between BATF and IRF1 and other factors that control CD4 + T-cell fate was not characterized in the study. How these findings affect the understanding of the balance and dynamics between Tr1 and Treg cells (the latter relying upon IL-2 for maintenance and survival 12 ) also requires further study. Notwithstanding these considerations, the findings from the study by Karwacz et al. 7 indicate new and important events in the dynamics of Tr1 cell generation and differentiation, and advance the knowledge of relevant mechanisms of immune tolerance, having the potential to ultimately lead to the modulation of the abnormal immune responses that characterize autoimmune disease.
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